Login / Register Submit Your Article
cover
Scientific Innovation in Asia

Volume 3, 2025 - Issue 1

Submit Manuscript Journal Homepage
Latest Issue
Input keywords, title, abstract, author, affiliation etc..
Article Menu
Browse this journal
Vol. 3 (2025)
Vol. 2 (2024)
Vol. 1 (2023)
Journal Article An open access journal
Open Access Journal Article

Advances in Non-Invasive Diagnostic Techniques for Heart Diseases: A Review

by Wenlong Wang 1 ,  Lina Wang 1 ,  Yishan Guo 1  and  Dong Wang 1
1
Department of Cardiology, Binzhou Medical University Hospital, No.661, Huanghe Second Road, Binzhou City, Shandong Province, 256699, China
*
Author to whom correspondence should be addressed.
SIA  2025 3(1):38; https://doi.org/10.12410/sia0201022
Received: 13 March 2025 / Accepted: 10 April 2025 / Published Online: 11 April 2025
View Full-Text
Download PDF

Abstract

Non-invasive diagnostic techniques have made significant strides in the early detection and management of cardiovascular diseases. Advances in imaging modalities, such as echocardiography, cardiac MRI (CMR), CT, and PET/SPECT, have enhanced diagnostic accuracy and allowed for detailed assessment of heart function and structure, while reducing the risks associated with invasive procedures. In parallel, the emergence of electrocardiography (ECG) and wearable devices has enabled real-time monitoring, aiding in the detection of arrhythmias and chronic disease management. Furthermore, blood-based biomarkers, including troponins, natriuretic peptides, and microRNAs, have shown promise for early detection, risk stratification, and prognosis prediction, although they often need to be integrated with imaging and ECG data for comprehensive evaluations. Artificial intelligence (AI) and machine learning are transforming cardiovascular diagnostics by improving image reconstruction, ECG interpretation, and multi-modal data integration, offering personalized assessments and enhanced diagnostic precision. However, challenges such as cost, accessibility, regulatory hurdles, and clinician adoption remain significant barriers. Future research should focus on improving the accessibility, affordability, and interoperability of diagnostic tools across healthcare systems. With continued innovation, non-invasive techniques are poised to play an increasingly pivotal role in early intervention and improved outcomes for patients with heart diseases.

Keywords: Non-Invasive Diagnostics; Cardiovascular Imaging; Electrocardiography (ECG); Wearable Health Technologies; Cardiac Biomarkers; Artificial Intelligence in Cardiology;
Copyright: © 2025 by Wang, Wang, Guo and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (Creative Commons Attribution 4.0 International License). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Share and Cite

ACS Style
Wang, W.; Wang, L.; Guo, Y.; Wang, D. Advances in Non-Invasive Diagnostic Techniques for Heart Diseases: A Review. Scientific Innovation in Asia, 2025, 3, 38. doi:10.12410/sia0201022
AMA Style
Wang W, Wang L, Guo Y et al.. Advances in Non-Invasive Diagnostic Techniques for Heart Diseases: A Review. Scientific Innovation in Asia; 2025, 3(1):38. doi:10.12410/sia0201022
Chicago/Turabian Style
Wang, Wenlong; Wang, Lina; Guo, Yishan; Wang, Dong 2025. "Advances in Non-Invasive Diagnostic Techniques for Heart Diseases: A Review" Scientific Innovation in Asia 3, no.1:38. doi:10.12410/sia0201022

Article Metrics

Article Access Statistics

References

  1. World Health Organization. Cardiovascular diseases (CVDs). WHO; 2021. Available from: https://www.who.int/
  2. Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics—2020 update: A report from the American Heart Association. Circulation. 2020;141(9):e139–e596.
  3. Patel MR, Calhoon JH, Dehmer GJ, et al. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 appropriate use criteria for coronary revascularization. J Am Coll Cardiol. 2017;69(17):2212–2241.
  4. Gulati M, Levy PD, Mukherjee D, et al. 2021 AHA/ACC guidelines for the evaluation and diagnosis of chest pain. J Am Coll Cardiol. 2021;78(22):e187–e285.
  5. Messroghli DR, Moon JC, Ferreira VM, et al. Clinical recommendations for cardiovascular magnetic resonance mapping. J Cardiovasc Magn Reson. 2017;19(1):75.
  6. Attia ZI, Friedman PA, Noseworthy PA, et al. Age and sex estimation using artificial intelligence from standard 12-lead ECGs. Circ Arrhythm Electrophysiol. 2019;12(9):e007284.
  7. de Gonzalo-Calvo D, van der Meer RW, Rijlaarsdam-Hermsen D, et al. Plasma microRNA profiling and cardiovascular disease risk assessment. J Am Heart Assoc. 2022;11(4):e023789.
  8. Hannun AY, Rajpurkar P, Haghpanahi M, et al. Cardiologist-level arrhythmia detection and classification in ambulatory electrocardiograms using a deep neural network. Nat Med. 2019;25(1):65–69.
  9. Fuster V, Kelly BB. Promoting cardiovascular health in the developing world: A critical challenge to achieve global health. National Academies Press; 2010.
  10. Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of stable ischemic heart disease. J Am Coll Cardiol. 2012;60(24):e44–e164.
  11. Mahabadi AA, Bamberg F, Toepker M, et al. Cardiac CT: Current practice and emerging techniques. Cardiovasc Diagn Ther. 2017;7(5):439–456.
  12. Lang RM, Badano LP, Victor MA, et al. Recommendations for cardiac chamber quantification by echocardiography in adults. Eur Heart J Cardiovasc Imaging. 2015;16(3):233–270.
  13. Thomas JD, Popović ZB. Assessment of left ventricular function by cardiac ultrasound. J Am Coll Cardiol. 2006;48(10):2012–2025.
  14. Karamitsos TD, Francis JM, Myerson S, et al. The role of cardiovascular magnetic resonance imaging in heart failure. J Am Coll Cardiol. 2009;54(16):1407–1424.
  15. Dorbala S, Di Carli MF, Beanlands RS, et al. Prognostic value of PET myocardial perfusion imaging. JACC Cardiovasc Imaging. 2021;14(6):1338–1353.
  16. Goldberger AL, Amaral LA, Glass L, et al. PhysioBank, PhysioToolkit, and PhysioNet: Components of a new research resource for complex physiologic signals. Circulation. 2000;101(23):e215–e220.
  17. Perez MV, Mahaffey KW, Hedlin H, et al. Large-scale assessment of a smartwatch to identify atrial fibrillation. N Engl J Med. 2019;381(20):1909–1917.
  18. Chapman AR, Lee KK, Anand A, et al. High-sensitivity cardiac troponin and the early rule out or diagnosis of myocardial infarction in patients presenting with chest pain. Circulation. 2017;135(23):2091–2101.
  19. Januzzi JL, Felker GM. Natriuretic peptides in heart failure: Measurement and significance. Cardiol Clin. 2018;36(2):223–240.
  20. Kuwabara Y, Ono K, Horie T, et al. Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage. Circ Cardiovasc Genet. 2011;4(4):446–454.
  21. Raghunath S, Pfeifer JM, Ulloa-Cerna AE, et al. Deep neural networks can predict new-onset atrial fibrillation from the 12-lead ECG. Nat Med. 2021;27(1):49–58.
  22. Ouyang D, He B, Ghorbani A, et al. Video-based AI for beat-to-beat assessment of cardiac function. Nature. 2020;580(7802):252–256.
  23. Attia ZI, Kapa S, Lopez-Jimenez F, et al. Screening for cardiac contractile dysfunction using an artificial intelligence-enabled ECG. Nat Med. 2019;25(1):70–74.
  24. Lang, R. M., Badano, L. P., Tsang, W., Adams, D. H., Agricola, E., Buck, T., & Khandheria, B. K. (2022). "EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography." Eur Heart J Cardiovasc Imaging, 23(5), 987-1020.
  25. Muraru, D., Niero, A., Rodriguez-Zanella, H., Cherata, D., Badano, L. P. (2021). "3D echocardiography in heart failure: A review of current applications and future directions." J Am Soc Echocardiogr, 34(6), 543-557.
  26. Senior, R., Becher, H., Monaghan, M., Agati, L., Zamorano, J. L. (2023). "Contrast-enhanced ultrasound: Advancing cardiac imaging." JACC Cardiovasc Imaging, 16(3), 312-329.
  27. Voigt, J. U., Pedrizzetti, G., Lysyansky, P., Marwick, T. H., Houle, H. (2022). "Strain imaging in echocardiography: From basics to clinical applications." Eur Heart J, 43(7), 814-829.
  28. Schwitter, J., Nanz, D., Kneifel, S., Bertschinger, K., Büchi, M. (2023). "T1/T2 mapping in cardiac MRI: A new frontier." Circ Cardiovasc Imaging, 16(4), 425-439.
  29. Winther, S., Nissen, L., Westra, J., Lassen, J. F., Dey, D. (2021). "AI-driven cardiac MRI: Clinical applications and future directions." Radiology, 302(1), 12-25.
  30. Willemink, M. J., Persson, M., Pourmorteza, A., Pelc, N. J., Fleischmann, D. (2023). "Photon-counting CT: Technological innovations and clinical applications." J Am Coll Cardiol, 81(9), 1120-1132.
  31. Nerlekar, N., Ha, F. J., Cheshire, C., Rashid, H., Nicholls, S. J. (2022). "AI and CT coronary angiography: Emerging tools for plaque assessment." Eur Heart J, 43(18), 1896-1907.
  32. Gould, K. L., Pan, T., Johnson, N. P., Guha, A., Morton, K. A. (2023). "PET myocardial perfusion imaging: Advancements and clinical implications." J Nucl Cardiol, 30(3), 625-643.
  33. Einstein, A. J., Blankstein, R., Andrews, H., Gottlieb, I., Miller, T. D. (2021). "CZT-based SPECT: Redefining myocardial perfusion imaging." JACC Cardiovasc Imaging, 14(7), 1345-1357.
  34. Slomka, P. J., Germano, G., Berman, D. S. (2023). "Artificial intelligence in nuclear cardiology: State-of-the-art and future prospects." J Nucl Med, 64(5), 702-717.
  35. Siontis, G. C., Ochoa, S., McLeod, A. P., & Prabhu, S. D. (2021). "Artificial intelligence in the interpretation of ECG signals: Current and future applications." J Electrocardiol, 60, 3-11.
  36. Zhang, Y., Wang, L., & Liu, L. (2022). "Personalized heart disease management using AI-driven ECG data analysis." J Med Syst, 46(7), 105.
  37. Ong, T., Thavapalan, D., & Cheung, C. (2021). "Smartwatches for detecting atrial fibrillation: A review of recent advancements." Cardiovasc Digital Health J, 2(4), 243-249.
  38. Huang, J., & Tan, J. (2023). "Telemedicine and wearable ECGs in managing chronic heart disease: A case study." J Telemed Telecare, 29(6), 365-373.
  39. Hayward, M. L., & Patel, A. K. (2021). "The role of telemedicine in heart disease management during the COVID-19 pandemic." J Am Coll Cardiol, 78(10), 911-918.
  40. Yu, W., Zhao, D., & Zhao, Y. (2023). "AI-powered ECG interpretation in smartwatches: A promising tool for arrhythmia detection." J Clin Eng, 48(1), 59-67.
  41. Kim, H., & Lee, H. (2022). "Advancements in wearable ECG devices for arrhythmia monitoring: AliveCor KardiaMobile as a case study." IEEE Trans Biomed Eng, 69(5), 2561-2569.
  42. Shifman, I., & Muller, J. (2021). "Remote monitoring of cardiovascular patients: The integration of wearable ECG and telemedicine." Telemed J E Health, 27(12), 1429-1435.
  43. Boeddinghaus, J., et al. (2022). "High-sensitivity troponin assays in acute myocardial infarction." Clin Chem, 68(5), 685-694.
  44. Shah, A. S., et al. (2021). "Troponin levels in stable coronary artery disease." J Am Coll Cardiol, 77(2), 103-114.
  45. McCullough, P. A., et al. (2022). "Natriuretic peptides in heart failure." J Am Coll Cardiol, 79(6), 523-533.
  46. Maisel, A. S., et al. (2021). "Role of natriuretic peptides in emergency heart failure diagnosis." JACC Cardiovasc Emerg, 22(3), 337-346.
  47. Bär, C., et al. (2022). "MicroRNAs in cardiovascular disease." Cardiovasc Res, 118(10), 2101-2113.
  48. Wang, J., et al. (2023). "MicroRNAs in acute myocardial infarction." J Clin Med, 12(7), 2117-2130.
  49. van der Meer, P., et al. (2021). "MicroRNA biomarkers for heart failure." Eur J Heart Fail, 23(8), 1289-1298.
  50. Liu, Y., et al. (2023). "Artificial intelligence in cardiovascular biomarker analysis." J Cardiovasc Transl Res, 16(2), 211-221.
  51. Zhang, Q., et al. (2022). "Next-generation sequencing for biomarker discovery in cardiovascular disease." J Am Heart Assoc, 11(3), 417-428.
  52. Lee, J., et al. (2023). "Challenges in integrating advanced imaging techniques in cardiovascular diagnostics." J Cardiac Imaging, 13(3), 220-229.
  53. Chen, L., et al. (2023). "The economics of advanced cardiac imaging." J Med Imaging, 21(7), 905-917.
  54. Zhang, Q., et al. (2022). "Recent advancements in wearable ECG technologies." Heart Rhythm, 19(8), 1345-1353.
  55. Zhang, J., et al. (2023). "AI-driven models in cardiac diagnostics." J Cardiovasc Comput, 19(4), 213-225.
  56. Brown, J., et al. (2022). "Barriers to the adoption of AI in healthcare." HealthTech, 6(3), 76-84.
  57. Nguyen, A., et al. (2022). "Integrating multi-modal data for cardiovascular diagnostics." J Cardiovasc Comput, 19(4), 213-225.
  58. Smith, L., et al. (2023). "Challenges in AI adoption in healthcare." J Med Innov, 9(1), 45-52.